Dexmedetomedine and Ketamine in Erector Spinae Block for Postoperative Analgesia Following Mastectomy.

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions

Breast Cancer

Interventions

DRUG

Bupivacaine Hydrochloride

injection of Bupivacaine 0.25% in ESPB

DRUG

Bupivacaine Hydrochloride and dexmedetomedine

injection of Bupivacaine 0.25% and dexmedetomedine in ESPB

DRUG

Bupivacaine Hydrochloride and ketamine

injection of Bupivacaine 0.25% and ketamine in ESPB

Trial Locations (1)

Hanafy, Cairo

All Listed Sponsors

lead

National Cancer Institute, Egypt

OTHER